Joint Corp Q3 net income turns positive to $855K; sells 45 clinics for $4.5M; adds $12M buyback

JOINT Corp

2025-Q3 EPS reported $0.12 revenue$39,728,545

Q3 revenue $13.4M (+6% YoY); consolidated net income $855K vs loss of $3.2M in Q3 2024.
Adjusted EBITDA from continuing ops $1.4M vs $262K in Q3 2024; consolidated adjusted EBITDA $3.3M (+36%).
Agreed to sell 45 Southern California clinics for $4.5M via asset purchase agreement (terms still being negotiated).
Board authorized additional $12M for stock repurchase program; 540K shares bought for $5M since program start.
Lowered FY2025 system-wide sales guidance to $530-534M and comp sales to (1)% to 0% from prior low-single-digit growth.

item 1.01item 2.02item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.